Amclin Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2018
- Revenue Growth -44.92%
- Profit Growth -417.68%
- Ebitda -645.96%
- Net Worth -82.16%
- Total Assets 27.61%
About Amclin Life Sciences
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74900PN2015PTC155009
- Company No.
155009
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 May 2015
- Date of AGM
28 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
What products or services does Amclin Life Sciences Private Limited offer?
Amclin Life Sciences Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Herbal Powder, Bottle Gourd Powder, Diabetic Herbal Medicine, Diabetic Herbal Tablets & Capsules, Herbal Capsules, Ashwagandha Capsules, Ayurvedic Tablets, Wheatgrass Tablet.
Who are the key members and board of directors at Amclin Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amol Lawande  | Director | 14-May-2015 | Current |
| Pratibha Lawande | Director | 14-May-2015 | Current |
| Ashok Lawande | Director | 14-May-2015 | Current |
Financial Performance of Amclin Life Sciences.
Amclin Life Sciences Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 44.92% decrease. The company also saw a substantial fall in profitability, with a 417.68% decrease in profit. The company's net worth observed a substantial decline by a decrease of 82.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amclin Life Sciences?
In 2018, Amclin Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amclin Life Sciences?
Unlock and access historical data on people associated with Amclin Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amclin Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amclin Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.